← All companies
PHAT
Phathom Pharmaceuticals, Inc.
$8.98
-0.05 -0.55%
Key statistics
from XBRL data in SEC filingsMarket cap
$726M
Revenue (TTM)
$240M
Net income (TTM)
$122M
EPS (TTM)
$-1.25
P/E ratio
—
Dividend yield
—
Free cash flow
-$167M
Cash
$182M
Total assets
$327M
Gross margin
82.9%
52-week range
$8.03 – $18.31
Recent SEC filings
40 most recentAnnual, quarterly & current reports
10-Q
Quarter ended 2026-06-30
Jul 30, 2026
8-K
Results of operations (earnings release)
Jul 30, 2026
8-K
Other events
Jun 23, 2026
8-K
Shareholder vote results
May 21, 2026
10-Q
Quarter ended 2026-03-31
Apr 30, 2026
8-K
Results of operations (earnings release)
Apr 30, 2026
10-K
Fiscal year ended 2025-12-31
Feb 26, 2026
8-K
Results of operations (earnings release)
Feb 26, 2026
8-K
Other events
Jan 8, 2026
8-K
Results of operations (earnings release)
Jan 7, 2026
8-K
Other events
Nov 4, 2025
10-Q
Quarter ended 2025-09-30
Oct 30, 2025
8-K
Results of operations (earnings release)
Oct 30, 2025
8-K
Other events
Oct 27, 2025
8-K
Director or officer change
Oct 6, 2025
10-Q
Quarter ended 2025-06-30
Aug 7, 2025
8-K
Results of operations (earnings release)
Aug 7, 2025
8-K
Other events
Jun 16, 2025
8-K
Shareholder vote results
Jun 9, 2025
8-K
Regulation FD disclosure; Other events
Jun 6, 2025
10-Q
Quarter ended 2025-03-31
May 1, 2025
8-K
Results of operations (earnings release)
May 1, 2025
8-K
Director or officer change
Apr 16, 2025
8-K
Director or officer change
Apr 1, 2025
8-K
Results of operations (earnings release)
Mar 6, 2025
10-K
Fiscal year ended 2024-12-31
Mar 6, 2025
8-K
Other events
Dec 11, 2024
10-Q
Quarter ended 2024-09-30
Nov 7, 2024
8-K
Results of operations (earnings release)
Nov 7, 2024
8-K
Other events
Aug 19, 2024
10-Q
Quarter ended 2024-06-30
Aug 8, 2024
8-K
Results of operations (earnings release)
Aug 8, 2024
8-K
Other events
Jul 18, 2024
10-K/A
Fiscal year ended 2023-12-31
Jun 14, 2024
10-Q/A
Quarter ended 2024-03-31
Jun 14, 2024
8-K
Shareholder vote results; Other events
May 24, 2024
10-Q
Quarter ended 2024-03-31
May 9, 2024
8-K
Results of operations (earnings release)
May 9, 2024
10-K
Fiscal year ended 2023-12-31
Mar 7, 2024
8-K
Results of operations (earnings release)
Mar 7, 2024